⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2026Chemical CommunicationsOpen Access

Correction: Pre-targeted delivery of a tetrazinylated albumin–zinc( ii ) porphyrin complex for tumor photodynamic therapy

Zheng Huang Yinxing Miao Xiaolei Zhao Deju Ye

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to correct previously published findings related to the delivery mechanism and efficacy of a specific drug complex in tumor treatment.
Correction of previous findings, which involved the use of tetrazinylated albumin-zinc porphyrin complex in photodynamic therapy.
Focus on the delivery mechanism and how it affects treatment results in tumors.
Correction acknowledged advancements in targeted drug delivery.
Improvements in therapeutic efficacy noted but specific numerical results not provided in correction.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Correction notes on drug delivery and effectiveness of photodynamic therapy in tumors, indicating significant advancements.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Huang et al. (2026) studied this question.

synapsesocial.com/papers/6a338cc3630953a74978df6b https://doi.org/10.1039/d6cc90194h

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Pre-targeted delivery of Tetrazinylated Albumin-Zinc (II) Porphyrin Complex for Tumor Photodynamic Therapy2025 · 1 citations
2Correction: The application of ICG-based photodynamic therapy combined with nanotechnology in tumor treatmentOriginal Research · 2026
3An Enzyme-responsive Porphyrin Metal-organic Framework Nanosystem for Targeted and Enhanced Synergistic Cancer Photo-chemo Therapy2024 · 3 citations
4Caged Ligand-Decorated Near-Infrared Photosensitizer with In Vivo Albumin-Hijacking Capacity for Tumor-Targeted Hypoxia-Tolerant Photoimmunotherapy of CancerIn Vitro Study · 2026 · 13 citations
5Controlled In Situ Self‐Assembly for Pretargeted Tumor Theranostics via Bioorthogonal ActivationOriginal Research · 2026

More related papers

Defect‐Engineered Tin Disulfide Nanocarriers as “Precision‐Guided Projectile” for Intensive Synergistic Therapy2024
Abstract 4317: A porphyrin-HDL nanoparticle for low-dose photodynamic therapy-induced antitumor immune activation2026
Phthalocyanines Conjugated with Small Biologically Active Compounds for the Advanced Photodynamic Therapy: A Review2025

More from Chemical Communications

Light-activated thiomaleimide crosslinking stabilizes collagen mimetic peptide triple helixThu,
Macrocyclic stibine-bridged [1.1.1] and [1.1.1.1] ferrocenophanesThu,